This is a table of type noun and their frequencies. Use it to search & browse the list to learn more about your study carrel.
noun | frequency |
---|---|
patients | 21272 |
cells | 9885 |
cell | 8929 |
disease | 5688 |
infection | 5184 |
transplantation | 5168 |
transplant | 4724 |
treatment | 4639 |
results | 3681 |
risk | 3674 |
donor | 3532 |
study | 3348 |
years | 3323 |
therapy | 3302 |
infections | 3286 |
days | 3249 |
months | 3094 |
virus | 3051 |
stem | 3010 |
group | 2978 |
patient | 2920 |
time | 2834 |
survival | 2761 |
recipients | 2735 |
age | 2682 |
blood | 2601 |
day | 2529 |
graft | 2425 |
analysis | 2379 |
response | 2290 |
data | 2223 |
methods | 2190 |
pts | 2080 |
cases | 2016 |
diagnosis | 1910 |
expression | 1902 |
conditioning | 1876 |
mortality | 1814 |
incidence | 1783 |
levels | 1763 |
dose | 1734 |
relapse | 1701 |
prophylaxis | 1700 |
donors | 1624 |
children | 1566 |
range | 1489 |
number | 1469 |
use | 1451 |
marrow | 1442 |
studies | 1399 |
conclusions | 1364 |
rate | 1350 |
mice | 1344 |
factors | 1341 |
liver | 1341 |
groups | 1339 |
bone | 1339 |
regimen | 1332 |
function | 1320 |
pneumonia | 1283 |
lung | 1283 |
failure | 1247 |
role | 1202 |
follow | 1195 |
outcome | 1180 |
year | 1163 |
grade | 1159 |
syndrome | 1153 |
type | 1134 |
antibody | 1127 |
effect | 1109 |
allogeneic | 1063 |
reactivation | 1062 |
gene | 1053 |
host | 1043 |
development | 1042 |
antigen | 1020 |
complications | 1017 |
case | 1011 |
disclosure | 1004 |
rejection | 1003 |
antibodies | 989 |
control | 982 |
diseases | 981 |
allo | 972 |
protein | 969 |
organ | 963 |
outcomes | 958 |
term | 944 |
leukemia | 937 |
samples | 928 |
activation | 928 |
period | 920 |
effects | 918 |
activity | 907 |
engraftment | 886 |
post | 884 |
level | 880 |
presence | 868 |
recipient | 867 |
ml | 860 |
median | 854 |
status | 848 |
kidney | 837 |
cohort | 837 |
population | 834 |
serum | 830 |
responses | 827 |
background | 813 |
none | 806 |
fever | 791 |
factor | 791 |
model | 790 |
viruses | 787 |
skin | 766 |
receptor | 764 |
production | 758 |
addition | 755 |
symptoms | 751 |
death | 748 |
weeks | 744 |
system | 731 |
lymphoma | 728 |
induction | 726 |
chemotherapy | 721 |
rates | 720 |
impact | 718 |
infants | 711 |
vaccine | 708 |
immunodeficiency | 700 |
test | 696 |
dna | 695 |
evidence | 689 |
remission | 675 |
phase | 662 |
sequence | 658 |
transplants | 653 |
interest | 653 |
conclusion | 652 |
lymphocytes | 646 |
kg | 635 |
immunosuppression | 633 |
detection | 632 |
progression | 631 |
sequences | 628 |
adult | 621 |
deficiency | 620 |
regimens | 619 |
increase | 619 |
toxicity | 616 |
recovery | 616 |
lymphocyte | 615 |
difference | 615 |
efficacy | 605 |
combination | 600 |
transmission | 599 |
agents | 598 |
care | 596 |
culture | 587 |
chimerism | 586 |
influenza | 584 |
ist | 583 |
cause | 577 |
breast | 576 |
onset | 573 |
differences | 571 |
milk | 568 |
tissue | 566 |
life | 563 |
drug | 562 |
count | 562 |
allograft | 559 |
source | 558 |
mutations | 555 |
proliferation | 554 |
trial | 552 |
method | 552 |
flow | 551 |
center | 551 |
criteria | 550 |
assay | 547 |
repertoire | 543 |
management | 543 |
line | 543 |
conflict | 542 |
heart | 540 |
tumor | 538 |
findings | 536 |
reduction | 535 |
immunity | 532 |
intensity | 530 |
hepatitis | 523 |
loss | 520 |
approach | 520 |
mutation | 518 |
evaluation | 517 |
family | 511 |
history | 508 |
frequency | 505 |
infusion | 500 |
testing | 499 |
plasma | 498 |
grafts | 484 |
genes | 483 |
course | 481 |
malignancies | 480 |
features | 480 |
hct | 479 |
score | 479 |
infant | 477 |
vivo | 476 |
doses | 475 |
value | 472 |
characteristics | 472 |
vaccination | 471 |
cytokine | 469 |
events | 469 |
adults | 468 |
experience | 464 |
cord | 462 |
duration | 460 |
absence | 460 |
tract | 457 |
reconstitution | 457 |
cancer | 455 |
stimulation | 455 |
platelet | 453 |
cytometry | 453 |
table | 451 |
immunoglobulin | 450 |
administration | 448 |
safety | 447 |
pathogens | 445 |
centers | 444 |
changes | 444 |
neutrophil | 444 |
total | 443 |
memory | 443 |
introduction | 443 |
antigens | 441 |
weight | 439 |
proteins | 439 |
class | 436 |
mechanism | 435 |
sibling | 433 |
procedure | 432 |
× | 429 |
presentation | 428 |
assays | 428 |
protocol | 427 |
mother | 421 |
controls | 418 |
adenovirus | 416 |
setting | 415 |
association | 414 |
involvement | 413 |
individuals | 413 |
load | 410 |
mechanisms | 406 |
gvhd | 406 |
biopsy | 403 |
der | 402 |
ratio | 398 |
majority | 398 |
prevention | 396 |
attention | 396 |
inflammation | 394 |
complication | 393 |
body | 393 |
cytokines | 393 |
order | 393 |
morbidity | 392 |
mobilization | 390 |
resistance | 387 |
strategy | 384 |
values | 383 |
lines | 382 |
hospital | 381 |
stage | 381 |
surface | 381 |
agvhd | 380 |
disorders | 379 |
phenotype | 378 |
illness | 376 |
numbers | 374 |
lesions | 372 |
contrast | 372 |
objectives | 372 |
target | 372 |
depletion | 371 |
comparison | 369 |
neutropenia | 367 |
improvement | 363 |
process | 359 |
strategies | 358 |
laboratory | 358 |
exposure | 358 |
co | 353 |
month | 350 |
sepsis | 347 |
end | 345 |
igg | 344 |
nothing | 342 |
myeloma | 342 |
auto | 342 |
conditions | 341 |
mg | 341 |
health | 341 |
review | 341 |
mouse | 341 |
tolerance | 341 |
subjects | 338 |
receptors | 338 |
quality | 335 |
dysfunction | 335 |
aim | 335 |
episodes | 333 |
anemia | 333 |
option | 332 |
molecules | 331 |
pathway | 329 |
generation | 329 |
size | 328 |
trials | 328 |
part | 324 |
injury | 324 |
drugs | 323 |
manifestations | 322 |
sequencing | 321 |
monitoring | 320 |
models | 320 |
series | 314 |
bacteria | 314 |
agent | 314 |
acid | 313 |
tests | 311 |
site | 311 |
information | 311 |
expansion | 310 |
apoptosis | 310 |
severity | 307 |
cultures | 306 |
selection | 304 |
screening | 304 |
diarrhea | 304 |
vector | 303 |
report | 303 |
cytomegalovirus | 303 |
analyses | 302 |
inhibitors | 300 |
correlation | 299 |
collection | 299 |
organs | 298 |
peptide | 294 |
result | 290 |
os | 290 |
subsets | 288 |
macrophages | 287 |
types | 287 |
markers | 286 |
growth | 286 |
prevalence | 285 |
capacity | 284 |
vaccines | 283 |
therapies | 283 |
reports | 283 |
prognosis | 283 |
performance | 279 |
lack | 279 |
potential | 278 |
date | 278 |
ability | 278 |
differentiation | 277 |
counts | 277 |
busulfan | 276 |
inhibitor | 276 |
causes | 275 |
parameters | 275 |
cgvhd | 274 |
steroid | 273 |
regulation | 273 |
guidelines | 273 |
breastfeeding | 273 |
steroids | 272 |
myeloid | 271 |
signs | 271 |
pattern | 270 |
pain | 269 |
procedures | 268 |
cyclophosphamide | 268 |
species | 267 |
sensitivity | 267 |
cr | 267 |
probability | 265 |
point | 264 |
authors | 264 |
week | 263 |
reaction | 263 |
hours | 263 |
unit | 262 |
products | 262 |
biopsies | 262 |
repertoires | 260 |
chain | 260 |
tuberculosis | 259 |
need | 258 |
identification | 258 |
times | 257 |
work | 256 |
viremia | 256 |
child | 255 |
form | 255 |
research | 254 |
women | 254 |
product | 253 |
event | 253 |
occurrence | 252 |
maintenance | 252 |
cyclosporine | 252 |
antibiotics | 249 |
release | 249 |
globulin | 248 |
effector | 248 |
support | 247 |
terms | 246 |
shock | 246 |
malignancy | 246 |
classification | 245 |
disorder | 243 |
membrane | 243 |
patterns | 242 |
replication | 242 |
varicella | 240 |
tissues | 240 |
spectrum | 239 |
regression | 239 |
region | 239 |
benefit | 239 |
decrease | 238 |
damage | 238 |
colitis | 238 |
side | 238 |
sample | 237 |
mothers | 237 |
cystitis | 237 |
contact | 237 |
concentration | 236 |
i | 236 |
proportion | 236 |
length | 235 |
search | 235 |
populations | 234 |
percentage | 234 |
assessment | 233 |
others | 232 |
ci | 232 |
organisms | 231 |
thrombocytopenia | 229 |
° | 228 |
interaction | 228 |
inhibition | 228 |
pathogen | 227 |
abnormalities | 226 |
protection | 225 |
countries | 225 |
world | 225 |
significance | 225 |
importance | 224 |
variants | 224 |
suppression | 224 |
state | 223 |
problem | 223 |
literature | 223 |
animals | 223 |
admission | 221 |
urine | 221 |
areas | 219 |
promoter | 218 |
self | 216 |
distribution | 216 |
datasets | 216 |
replacement | 215 |
practice | 214 |
profile | 214 |
volume | 213 |
specificity | 213 |
gram | 213 |
a. | 213 |
transfer | 212 |
signal | 212 |
mud | 212 |
immunization | 212 |
formation | 212 |
application | 212 |
necrosis | 211 |
ventilation | 210 |
neutrophils | 210 |
functions | 210 |
motif | 209 |
points | 209 |
salvage | 208 |
copies | 207 |
sex | 206 |
concentrations | 206 |
variant | 205 |
transcription | 205 |
titers | 205 |
pneumoniae | 205 |
isolation | 205 |
transfusion | 204 |
sites | 204 |
resolution | 204 |
fibrosis | 204 |
cost | 204 |
spleen | 203 |
deaths | 203 |
aspergillus | 202 |
haplo | 202 |
gamma | 202 |
male | 201 |
specimens | 200 |
networks | 200 |
initiation | 200 |
variables | 198 |
sign | 198 |
interactions | 198 |
properties | 196 |
vectors | 195 |
tacrolimus | 195 |
secretion | 195 |
posttransplant | 195 |
peptides | 195 |
monocytes | 195 |
fludarabine | 194 |
treatments | 194 |
input | 193 |
strains | 191 |
chest | 191 |
herpes | 191 |
dl | 190 |
dataset | 190 |
brain | 190 |
irradiation | 190 |
susceptibility | 190 |
burden | 189 |
marker | 188 |
car | 187 |
interval | 186 |
community | 186 |
zoster | 185 |
apheresis | 185 |
allografts | 185 |
defects | 184 |
signals | 184 |
infusions | 184 |
pathogenesis | 183 |
basis | 182 |
validation | 181 |
immunotherapy | 181 |
degree | 181 |
tumors | 180 |
pressure | 180 |
pregnancy | 180 |
creatinine | 180 |
approaches | 180 |
gut | 179 |
examination | 179 |
aureus | 179 |
hr | 178 |
alpha | 177 |
hospitalization | 177 |
corticosteroids | 177 |
experiments | 177 |
index | 177 |
program | 177 |
yrs | 177 |
institution | 177 |
platelets | 176 |
interferon | 176 |
challenge | 176 |
relationship | 175 |
regions | 175 |
survivors | 174 |
recognition | 174 |
oder | 174 |
nephropathy | 174 |
area | 173 |
males | 172 |
humans | 172 |
cycle | 171 |
genome | 171 |
motifs | 171 |
measles | 171 |
binding | 170 |
pneumonitis | 169 |
gender | 169 |
change | 169 |
polymerase | 168 |
hand | 166 |
techniques | 166 |
females | 165 |
als | 165 |
survey | 165 |
lymph | 165 |
maturation | 165 |
microscopy | 164 |
lungs | 164 |
choice | 164 |
consolidation | 163 |
condition | 163 |
strain | 163 |
isolates | 163 |
trend | 163 |
diabetes | 162 |
mscs | 161 |
ganciclovir | 161 |
fluid | 161 |
origin | 160 |
objective | 160 |
ligand | 160 |
genotype | 159 |
units | 159 |
protocols | 159 |
risks | 158 |
recurrence | 158 |
ng | 158 |
dengue | 158 |
inclusion | 157 |
cycles | 157 |
knowledge | 157 |
recommendations | 157 |
islet | 156 |
example | 156 |
enzyme | 156 |
beta | 156 |
aspergillosis | 156 |
arm | 156 |
problems | 155 |
instances | 155 |
instance | 154 |
variety | 153 |
scores | 153 |
mitochondria | 153 |
network | 152 |
autoimmunity | 152 |
era | 152 |
surgery | 152 |
observation | 152 |
staining | 152 |
mismatch | 151 |
donation | 151 |
domain | 151 |
art | 151 |
airway | 151 |
update | 150 |
pathways | 150 |
influence | 150 |
delivery | 150 |
centre | 150 |
persons | 149 |
parents | 149 |
animal | 148 |
baseline | 148 |
deletion | 148 |
panel | 147 |
indication | 147 |
hypertension | 147 |
cross | 146 |
childhood | 146 |
candidates | 146 |
set | 145 |
min | 145 |
infiltration | 145 |
cohorts | 145 |
options | 144 |
database | 144 |
forms | 144 |
colonization | 144 |
placebo | 144 |
processes | 144 |
registry | 144 |
toxicities | 143 |
surveillance | 143 |
pt | 143 |
pathology | 143 |
intervention | 142 |
kidneys | 142 |
migration | 142 |
members | 140 |
medications | 140 |
kinase | 140 |
candidiasis | 140 |
allele | 140 |
tool | 139 |
imaging | 139 |
leukaemia | 137 |
technique | 137 |
phosphorylation | 136 |
media | 136 |
defect | 136 |
context | 136 |
clearance | 136 |
blasts | 136 |
amount | 136 |
summary | 136 |
bal | 135 |
responders | 135 |
mab | 135 |
etiology | 134 |
purpose | 133 |
molecule | 133 |
materials | 133 |
fact | 132 |
amphotericin | 132 |
bacteremia | 132 |
plerixafor | 132 |
standard | 132 |
reactions | 132 |
step | 131 |
sources | 131 |
respect | 131 |
ligands | 131 |
cytotoxicity | 131 |
settings | 130 |
measures | 130 |
contribution | 130 |
complex | 130 |
calcium | 130 |
ad | 130 |
n=2 | 129 |
epitope | 129 |
injection | 128 |
percent | 128 |
possibility | 127 |
vs. | 127 |
female | 126 |
centres | 125 |
syndromes | 125 |
plasmid | 125 |
investigation | 125 |
indications | 125 |
p. | 124 |
n=3 | 123 |
rituximab | 122 |
impairment | 122 |
complement | 122 |
coli | 122 |
pairs | 121 |
discontinuation | 121 |
consensus | 121 |
prediction | 121 |
thalassemia | 121 |
systems | 121 |
ischemia | 120 |
dcs | 120 |
hyperparameter | 120 |
efficiency | 120 |
processing | 120 |
training | 120 |
transfusions | 120 |
β | 119 |
stages | 119 |
learning | 119 |
spp | 118 |
ptcy | 118 |
fungi | 117 |
fraction | 117 |
bowel | 117 |
reasons | 117 |
technology | 117 |
understanding | 116 |
mmf | 116 |
immune | 116 |
concern | 116 |
mass | 115 |
epidemiology | 115 |
man | 115 |
peak | 115 |
rash | 115 |
targets | 115 |
records | 114 |
organism | 114 |
ferritin | 114 |
csf | 114 |
category | 114 |
hypothesis | 113 |
arthritis | 113 |
characterization | 113 |
cidofovir | 113 |
siblings | 113 |
reference | 113 |
start | 113 |
success | 113 |
stress | 112 |
macrophage | 112 |
components | 112 |
birth | 112 |
bag | 112 |
progenitor | 112 |
simplex | 111 |
scale | 111 |
meningitis | 111 |
leukocyte | 111 |
killer | 111 |
episode | 111 |
clones | 111 |
coronavirus | 110 |
access | 110 |
amino | 110 |
machine | 110 |
diversity | 110 |
mrna | 110 |
medium | 110 |
timing | 109 |
stay | 109 |
ribavirin | 109 |
availability | 109 |
way | 108 |
alternative | 108 |
transplantations | 107 |
position | 107 |
nature | 107 |
herpesvirus | 107 |
frequencies | 106 |
half | 106 |
nodes | 106 |
yield | 105 |
tumour | 105 |
periods | 105 |
pancreas | 105 |
lymphomas | 105 |
endpoint | 105 |
manner | 104 |
kit | 104 |
hypogammaglobulinemia | 104 |
environment | 104 |
dysregulation | 104 |
design | 104 |
field | 103 |
component | 103 |
device | 103 |
sets | 103 |
pooling | 103 |
thymus | 103 |
viability | 103 |
ifng | 102 |
epitopes | 102 |
title | 101 |
pbmcs | 101 |
particles | 101 |
manifestation | 101 |
limitations | 101 |
fluconazole | 101 |
adv | 101 |
appearance | 100 |
cm | 100 |
hazard | 100 |
action | 100 |
diagnoses | 100 |
csa | 100 |
immunodeficiencies | 100 |
men | 100 |
mononuclear | 100 |
novel | 100 |
⩾ | 100 |
nephritis | 99 |
hat | 99 |
hosts | 99 |
interventions | 99 |
reperfusion | 99 |
oxygen | 99 |
titer | 99 |
transduction | 99 |
water | 99 |
hemorrhage | 98 |
complexes | 98 |
fusion | 98 |
candidate | 98 |
medication | 98 |
retinitis | 98 |
mg/ | 98 |
parvovirus | 97 |
goal | 97 |
edema | 97 |
categories | 97 |
finding | 96 |
asthma | 96 |
fi | 96 |
image | 96 |
preparation | 96 |
serology | 96 |
subset | 95 |
reason | 95 |
mean | 95 |
loads | 95 |
incidences | 95 |
blockade | 95 |
acids | 95 |
muscle | 94 |
kinetics | 94 |
label | 94 |
toxoplasmosis | 94 |
people | 94 |
recruitment | 94 |
ul | 93 |
relapses | 93 |
obstruction | 93 |
insulin | 93 |
helper | 93 |
distress | 93 |
catheter | 93 |
biomarkers | 93 |
journal | 92 |
cord_uid | 92 |
immunosequencing | 92 |
implications | 92 |
hyperparameters | 92 |
lipid | 92 |
reactivity | 92 |
μl | 92 |
proteinuria | 92 |
minutes | 91 |
affinity | 91 |
albumin | 91 |
chromosome | 91 |
cough | 91 |
quantification | 91 |
section | 91 |
stool | 91 |
toxin | 91 |
variability | 91 |
cytogenetics | 90 |
adhesion | 90 |
colony | 90 |
consideration | 90 |
content | 90 |
ctls | 90 |
predictors | 90 |
leukocytes | 90 |
measurement | 90 |
participants | 90 |
persistence | 90 |
log | 90 |
nausea | 89 |
measurements | 89 |
iron | 89 |
histology | 89 |
effectiveness | 89 |
dialysis | 89 |
fluorescence | 88 |
comorbidities | 88 |
curve | 88 |
discharge | 88 |
deficiencies | 88 |
kernel | 88 |
physicians | 88 |
transformer | 88 |
situation | 88 |
solution | 88 |
accumulation | 87 |
advantage | 87 |
cap | 87 |
decision | 87 |
decline | 87 |
domains | 87 |
gain | 87 |
islets | 87 |
layer | 87 |
outbreaks | 87 |
amplification | 86 |
discussion | 86 |
clinicians | 86 |
consent | 86 |
courses | 86 |
regard | 86 |
electron | 86 |
foscarnet | 86 |
material | 86 |
tag | 86 |
feasibility | 86 |
subgroup | 85 |
structure | 85 |
lineage | 85 |
human | 85 |
feature | 85 |
mm | 84 |
immunoglobulins | 84 |
inclusions | 84 |
rat | 84 |
storage | 84 |
threshold | 83 |
reactivations | 83 |
plant | 83 |
match | 83 |
hscs | 83 |
composition | 83 |
carcinoma | 83 |
issue | 82 |
activities | 82 |
corticosteroid | 82 |
cure | 82 |
evolution | 82 |
intervals | 82 |
issues | 82 |
lfs | 82 |
pcr | 82 |
phenotypes | 82 |
platform | 82 |
symptom | 82 |
rank | 81 |
profiles | 81 |
positivity | 81 |
leaf | 81 |
lavage | 81 |
delay | 81 |
cryopreservation | 81 |
chemokines | 81 |
adolescents | 80 |
exome | 80 |
individual | 80 |
question | 80 |
temperature | 79 |
synthesis | 79 |
signaling | 79 |
serotypes | 79 |
mode | 79 |
lesion | 79 |
incubation | 79 |
grades | 79 |
families | 79 |
extent | 79 |
food | 78 |
clinic | 78 |
colon | 78 |
contamination | 78 |
aspects | 78 |
list | 78 |
pneumonias | 78 |
relevance | 78 |
software | 78 |
plants | 78 |
feeding | 77 |
consequences | 77 |
details | 77 |
adherence | 77 |
object | 77 |
person | 77 |
predictor | 77 |
progress | 77 |
withdrawal | 76 |
stability | 76 |
home | 76 |
die | 76 |
costs | 76 |
bronchiolitis | 76 |
abscesses | 76 |
combinations | 75 |
amounts | 75 |
applications | 75 |
autoantibodies | 75 |
benefits | 75 |
one | 75 |
consequence | 75 |
dosing | 75 |
malaria | 75 |
mucosa | 75 |
subgroups | 75 |
tyrosine | 74 |
observations | 74 |
leukopenia | 74 |
depression | 74 |
cytopenias | 74 |
compartment | 74 |
output | 73 |
efs | 73 |
fevers | 73 |
fungal | 73 |
genotypes | 73 |
sind | 73 |
physician | 73 |
version | 73 |
spread | 73 |
suspicion | 73 |
sarcoma | 73 |
immunogenicity | 72 |
alterations | 72 |
blot | 72 |
determination | 72 |
dynamics | 72 |
fluids | 72 |
challenges | 72 |
kernels | 72 |
primers | 72 |
rise | 72 |
progenitors | 72 |
rats | 72 |
paper | 72 |
fatigue | 71 |
bloodstream | 71 |
detail | 71 |
secretions | 71 |
space | 71 |
bladder | 70 |
cancers | 70 |
density | 70 |
n=8 | 70 |
formula | 70 |
karyotype | 70 |
matching | 70 |
emergence | 70 |
nach | 70 |
sputum | 70 |
team | 70 |
th1 | 70 |
upregulation | 70 |
utility | 70 |
voriconazole | 70 |
precautions | 70 |
repair | 69 |
focus | 69 |
fragments | 69 |
glucose | 69 |
representation | 69 |
rest | 69 |
sclerosis | 69 |
subunit | 69 |
variation | 69 |
hepatocytes | 68 |
abscess | 68 |
dosage | 68 |
fragment | 68 |
gradient | 68 |
granulocytes | 68 |
headache | 68 |
splenomegaly | 68 |
immunofluorescence | 68 |
implementation | 68 |
modification | 68 |
place | 68 |
radiotherapy | 68 |
subtypes | 68 |
terminal | 68 |
insights | 67 |
aeruginosa | 67 |
blast | 67 |
cdna | 67 |
chemokine | 67 |
copy | 67 |
grid | 67 |
endpoints | 67 |
mismatches | 67 |
requirement | 67 |
separation | 67 |
sirolimus | 67 |
supernatants | 67 |
vein | 67 |
wound | 67 |
node | 66 |
alloreactivity | 66 |
alveolar | 66 |
enzymes | 66 |
epithelium | 66 |
exon | 66 |
immunohistochemistry | 66 |
advances | 66 |
rabbit | 66 |
room | 66 |
route | 66 |
sct | 66 |
streptococcus | 66 |
thymocytes | 66 |
radiation | 66 |
programs | 65 |
bleeding | 65 |
complexity | 65 |
degradation | 65 |
diarrhoea | 65 |
infiltrates | 65 |
schedule | 65 |
sub | 65 |
subpopulations | 65 |
tetanus | 65 |
trough | 65 |
epidemic | 64 |
+100 | 64 |
biology | 64 |
cirrhosis | 64 |
costimulation | 64 |
country | 64 |
decade | 64 |
delta | 64 |
entry | 64 |
rubella | 64 |
insufficiency | 64 |
lupus | 64 |
matrix | 64 |
metabolism | 64 |
microorganisms | 64 |
mycoplasma | 64 |
nf | 64 |
vomiting | 64 |
investigations | 64 |
mouth | 63 |
acquisition | 63 |
apcs | 63 |
flu | 63 |
microbiota | 63 |
neonates | 63 |
polymorphisms | 63 |
pool | 63 |
situations | 63 |
ulcers | 63 |
granulocyte | 62 |
adenoviruses | 62 |
basal | 62 |
batch | 62 |
cd40l | 62 |
decades | 62 |
fibroblasts | 62 |
lysis | 62 |
member | 62 |
party | 62 |
pg | 62 |
proteasome | 62 |
regulator | 62 |
rule | 62 |
staff | 62 |
transformation | 62 |
für | 61 |
account | 61 |
b6 | 61 |
candida | 61 |
defibrotide | 61 |
enhancer | 61 |
glycoprotein | 61 |
hemoglobin | 61 |
increases | 61 |
membranes | 61 |
power | 61 |
preservation | 61 |
ray | 61 |
mediators | 61 |
influenzae | 60 |
difficile | 60 |
incompatibility | 60 |
illnesses | 60 |
carrier | 60 |
accuracy | 60 |
mellitus | 60 |
mast | 60 |
letermovir | 60 |
mononucleosis | 60 |
myocarditis | 60 |
nm | 60 |
ones | 60 |
precursor | 60 |
project | 60 |
roles | 60 |
thrombosis | 60 |
difficulties | 59 |
alleles | 59 |
array | 59 |
coverage | 59 |
deposition | 59 |
arms | 59 |
implantation | 59 |
livers | 59 |
pilot | 59 |
uptake | 59 |
removal | 59 |
abundance | 58 |
attempt | 58 |
concerns | 58 |
conversion | 58 |
gastroenteritis | 58 |
hematuria | 58 |
hybridization | 58 |
likelihood | 58 |
modality | 58 |
outbreak | 58 |
usage | 58 |
cd45ra | 57 |
deterioration | 57 |
core | 57 |
confidence | 57 |
encephalopathy | 57 |
catheters | 57 |
bronchiectasis | 57 |
artery | 57 |
efforts | 57 |
help | 57 |
laboratories | 57 |
modulation | 57 |
pandemic | 57 |
pertussis | 57 |
screen | 57 |
seizures | 57 |
syngeneic | 57 |
lab | 57 |
mcl | 56 |
il-2 | 56 |
characters | 56 |
endocarditis | 56 |
etiologies | 56 |
ex | 56 |
future | 56 |
plasmids | 56 |
mycobacteria | 56 |
nkg2d | 56 |
posttransplantation | 56 |
questionnaire | 56 |
relation | 56 |
rescue | 56 |
translocation | 56 |
chapter | 55 |
associations | 55 |
bodies | 55 |
beam | 55 |
effusion | 55 |
air | 55 |
8) | 55 |
definition | 55 |
circulation | 55 |
infl | 55 |
switch | 55 |
functioning | 55 |
mo | 55 |
parameter | 55 |
polymorphism | 55 |
scan | 55 |
variable | 55 |
elimination | 55 |
manuscript | 54 |
barrier | 54 |
calcineurin | 54 |
chains | 54 |
exchange | 54 |
killing | 54 |
recombination | 54 |
means | 54 |
mucositis | 54 |
subtype | 54 |
tolerability | 54 |
war | 54 |
sd | 54 |
grading | 53 |
immunosuppressants | 53 |
defense | 53 |
gas | 53 |
healing | 53 |
concept | 53 |
albicans | 53 |
agonist | 53 |
manufacturing | 53 |
limit | 53 |
improvements | 53 |
neoplasms | 53 |
α | 53 |
requirements | 53 |
restriction | 53 |
transfection | 53 |
valganciclovir | 53 |
vancomycin | 53 |
variations | 53 |
vessels | 53 |
woman | 53 |
pids | 53 |
enhancement | 52 |
gvl | 52 |
folds | 52 |
failures | 52 |
exclusion | 52 |
aas | 52 |
comorbidity | 52 |
colleagues | 52 |
chance | 52 |
bilirubin | 52 |
interpretation | 52 |
harvest | 52 |
boy | 52 |
localization | 52 |
sickle | 52 |
vasculitis | 52 |
typing | 52 |
states | 52 |
smallpox | 52 |
throughput | 52 |
serostatus | 52 |
priming | 52 |
policy | 52 |
picture | 52 |
otitis | 52 |
nutrition | 52 |
neuroblastoma | 51 |
ab | 51 |
advantages | 51 |
dissemination | 51 |
elevation | 51 |
glomerulonephritis | 51 |
key | 51 |
max | 51 |
outpatient | 51 |
phagocytosis | 51 |
photopheresis | 51 |
pr | 51 |
race | 51 |
ultrasound | 51 |
wt | 51 |
parent | 51 |
infancy | 50 |
actin | 50 |
coefficient | 50 |
curl | 50 |
dock8 | 50 |
education | 50 |
non | 50 |
light | 50 |
newborns | 50 |
osteomyelitis | 50 |
overview | 50 |
transcripts | 50 |
wall | 50 |
drainage | 49 |
enrichment | 49 |
endoscopy | 49 |
loci | 49 |
diphtheria | 49 |
coagulation | 49 |
injections | 49 |
n=7 | 49 |
n=9 | 49 |
positions | 49 |
probabilities | 49 |
qol | 49 |
rotavirus | 49 |
sequelae | 49 |
transgene | 49 |
clostridium | 48 |
leukapheresis | 48 |
entity | 48 |
embedding | 48 |
1a | 48 |
chart | 48 |
biomarker | 48 |
average | 48 |
nk | 48 |
locus | 48 |
note | 48 |
oedema | 48 |
rag | 48 |
ranges | 48 |
rapamycin | 48 |
repeat | 48 |
specifi | 48 |
stain | 48 |
tools | 48 |
quantitation | 48 |
eczema | 47 |
collections | 47 |
instability | 47 |
alemtuzumab | 47 |
location | 47 |
fumigatus | 47 |
lymphadenopathy | 47 |
view | 47 |
practices | 47 |
steps | 47 |
structures | 47 |
substitution | 47 |
methicillin | 47 |
tomography | 47 |
link | 46 |
exposures | 46 |
hyperplasia | 46 |
framework | 46 |
fashion | 46 |
dermatitis | 46 |
enterovirus | 46 |
devices | 46 |
ii | 46 |
clone | 46 |
barriers | 46 |
hypotension | 46 |
measure | 46 |
infiltrate | 46 |
mastitis | 46 |
mumps | 46 |
nodules | 46 |
pharmacokinetics | 46 |
purpura | 46 |
quantity | 46 |
regeneration | 46 |
seroconversion | 46 |
throat | 46 |
algorithm | 46 |
diagnostics | 45 |
heterogeneity | 45 |
healthcare | 45 |
kinases | 45 |
costimulatory | 45 |
adjustment | 45 |
invasion | 45 |
igm | 45 |
sin | 45 |
mm3 | 45 |
ratios | 45 |
rr | 45 |
rst | 45 |
toxoplasma | 45 |
medicine | 45 |
subject | 45 |
girl | 44 |
hemolysis | 44 |
chimeras | 44 |
contributions | 44 |
egfr | 44 |
esophagitis | 44 |
extraction | 44 |
guideline | 44 |
hearts | 44 |
insight | 44 |
lymphoproliferation | 44 |
microarray | 44 |
mitogen | 44 |
percentages | 44 |
proportions | 44 |
stimuli | 44 |
translation | 44 |
trends | 44 |
volunteers | 44 |
comparisons | 43 |
exception | 43 |
establishment | 43 |
encephalitis | 43 |
durchgeführt | 43 |
difficulty | 43 |
serotype | 43 |
cd3 | 43 |
cavity | 43 |
beginning | 43 |
ascites | 43 |
antifungal | 43 |
hour | 43 |
homeostasis | 43 |
son | 43 |
ifnγ | 43 |
manipulation | 43 |
mdc | 43 |
missense | 43 |
mold | 43 |
nasal | 43 |
overload | 43 |
questions | 43 |
rhinovirus | 43 |
shift | 43 |
travel | 43 |
workers | 43 |
hscts | 42 |
hospitalizations | 42 |
hrs | 42 |
manufacturer | 42 |
infarction | 42 |
insertion | 42 |
department | 42 |
discovery | 42 |
protease | 42 |
cv | 42 |
curves | 42 |
conjugate | 42 |
carriers | 42 |
booster | 42 |
boost | 42 |
aspiration | 42 |
= | 42 |
neutralization | 42 |
mutants | 42 |
stat1 | 42 |
pet | 42 |
sinusitis | 42 |
phases | 42 |
weaning | 42 |
tube | 42 |
trauma | 42 |
tnfa | 42 |
tendency | 42 |
witness | 42 |
vaccinations | 42 |
signifi | 42 |
seropositivity | 42 |
primer | 42 |
preparations | 42 |
precursors | 42 |
phenomenon | 42 |
signalling | 42 |
column | 41 |
fetus | 41 |
examples | 41 |
degrees | 41 |
compounds | 41 |
compound | 41 |
adjuvant | 41 |
chemo | 41 |
antivirals | 41 |
acyclovir | 41 |
abnormality | 41 |
hematology | 41 |
fractions | 41 |
multidrug | 41 |
sodium | 41 |
optimization | 41 |
pid | 41 |
potency | 41 |
query | 41 |
recommendation | 41 |
saline | 41 |
sister | 41 |
subunits | 41 |
utilization | 41 |
neck | 41 |
vaccinia | 41 |
constructs | 40 |
complaints | 40 |
confirmation | 40 |
deposits | 40 |
decisions | 40 |
cleavage | 40 |
collagen | 40 |
ages | 40 |
chikungunya | 40 |
capture | 40 |
bile | 40 |
bacilli | 40 |
auf | 40 |
/kg | 40 |
demographics | 40 |
cut | 40 |
dexamethasone | 40 |
genomes | 40 |
dimension | 40 |
workup | 40 |
supernatant | 40 |
queries | 40 |
pair | 40 |
mobilisation | 40 |
signature | 40 |
foxp3 | 40 |
estimates | 40 |
errors | 40 |
envelope | 40 |
eculizumab | 40 |
doi | 40 |
deviation | 39 |
institutions | 39 |
hsv-1 | 39 |
haplotype | 39 |
gel | 39 |
fold | 39 |
eye | 39 |
experts | 39 |
ed | 39 |
approval | 39 |
contacts | 39 |
cmv | 39 |
brother | 39 |
bm | 39 |
base | 39 |
atrophy | 39 |
isoforms | 39 |
anaemia | 39 |
-1 | 39 |
intestine | 39 |
needs | 39 |
ltx | 39 |
representations | 39 |
γ | 39 |
waiting | 39 |
ventilator | 39 |
suppressor | 39 |
specimen | 39 |
mobilizers | 39 |
sections | 39 |
scans | 39 |
sheep | 39 |
rationale | 39 |
purity | 39 |
pretreatment | 39 |
pre | 39 |
pig | 39 |
pc | 39 |
parasites | 39 |
n=1 | 39 |
con | 38 |
incorporation | 38 |
homology | 38 |
granulomas | 38 |
eradication | 38 |
crop | 38 |
cp | 38 |
counseling | 38 |
kits | 38 |
cholesterol | 38 |
buffer | 38 |
boys | 38 |
botulism | 38 |
bias | 38 |
bags | 38 |
antibiotic | 38 |
investigators | 38 |
agreement | 38 |
luciferase | 38 |
residues | 38 |
modalities | 38 |
third | 38 |
suspension | 38 |
subpopulation | 38 |
standards | 38 |
stabilization | 38 |
segments | 38 |
yr | 38 |
resection | 38 |
probes | 38 |
probe | 38 |
phosphatase | 38 |
parasite | 38 |
oxidase | 38 |
organization | 38 |
rabies | 38 |
desensitization | 37 |
funding | 37 |
erythematosus | 37 |
erfolgt | 37 |
enteritis | 37 |
engagement | 37 |
endotoxin | 37 |
elements | 37 |
avium | 37 |
cutoff | 37 |
beads | 37 |
backbone | 37 |
attempts | 37 |
atm | 37 |
accordance | 37 |
h. | 37 |
genus | 37 |
methylation | 37 |
immunology | 37 |
reporter | 37 |
zone | 37 |
weights | 37 |
vod | 37 |
keys | 37 |
transport | 37 |
tandem | 37 |
seroprevalence | 37 |
vesicles | 37 |
prednisone | 37 |
pathogenicity | 37 |
normalization | 37 |
monotherapy | 37 |
moment | 37 |
lysates | 37 |
pericarditis | 37 |
effort | 36 |
herpesviruses | 36 |
functionality | 36 |
endothelium | 36 |
eines | 36 |
anti | 36 |
awareness | 36 |
author | 36 |
allocation | 36 |
images | 36 |
histopathology | 36 |
pathophysiology | 36 |
intubation | 36 |
oxide | 36 |
parallel | 36 |
washing | 36 |
presentations | 36 |
propagation | 36 |
regulators | 36 |
restoration | 36 |
situ | 36 |
visit | 36 |
latency | 36 |
hematopoiesis | 35 |
minimum | 35 |
matter | 35 |
isolate | 35 |
hypoxia | 35 |
communication | 35 |
filtration | 35 |
eyes | 35 |
effusions | 35 |
compartments | 35 |
ova | 35 |
24h | 35 |
multiplex | 35 |
knockout | 35 |
percentile | 35 |
splenectomy | 35 |
perfusion | 35 |
vessel | 35 |
turn | 35 |
strength | 35 |
spots | 35 |
toll | 35 |
segment | 35 |
scheme | 35 |
resource | 35 |
radiograph | 35 |
pi | 35 |
graftversus | 34 |
major | 34 |
lymphohistiocytosis | 34 |
loading | 34 |
interleukin | 34 |
inability | 34 |
household | 34 |
hospitals | 34 |
balance | 34 |
frame | 34 |
filter | 34 |
face | 34 |
epidemics | 34 |
encoding | 34 |
bridge | 34 |
anastomosis | 34 |
objects | 34 |
maximum | 34 |
article | 34 |
overexpression | 34 |
sinus | 34 |
μg | 34 |
™ | 34 |
vor | 34 |
viraemia | 34 |
versushost | 34 |
tumours | 34 |
telomere | 34 |
overlap | 34 |
responsiveness | 34 |
refractory | 34 |
pylori | 34 |
pools | 34 |
plate | 34 |
phenotyping | 34 |
pharyngitis | 34 |
parts | 34 |
glomeruli | 33 |
girls | 33 |
falciparum | 33 |
energy | 33 |
emergency | 33 |
dysplasia | 33 |
behalf | 33 |
chronic | 33 |
cessation | 33 |
bet | 33 |
homing | 33 |
alteration | 33 |
allergy | 33 |
agonists | 33 |
hair | 33 |
diameter | 33 |
immunoassay | 33 |
relatives | 33 |
lineages | 33 |
weakness | 33 |
statistics | 33 |
ssc | 33 |
shedding | 33 |
sensitization | 33 |
resources | 33 |
formulation | 33 |
rearrangements | 33 |
postpartum | 33 |
noise | 33 |
minority | 33 |
malaise | 33 |
proof | 33 |
losses | 33 |
escape | 32 |
cytoplasm | 32 |
destruction | 32 |
diet | 32 |
erythema | 32 |
father | 32 |
estimation | 32 |
conjunction | 32 |
grant | 32 |
height | 32 |
histoplasmosis | 32 |
criterion | 32 |
collaboration | 32 |
completion | 32 |
colonies | 32 |
cassette | 32 |
bronchoscopy | 32 |
avidity | 32 |
autophagy | 32 |
alternatives | 32 |
allohsct | 32 |
admissions | 32 |
+ | 32 |
inhalation | 32 |
architectures | 32 |
identity | 32 |
intolerance | 32 |
rodent | 32 |
lad | 32 |
ß | 32 |
virulence | 32 |
uence | 32 |
trachomatis | 32 |
supply | 32 |
submission | 32 |
staphylococci | 32 |
splicing | 32 |
splice | 32 |
scoring | 32 |
transcript | 32 |
retransplantation | 32 |
operation | 32 |
predisposition | 32 |
limits | 32 |
magnitude | 32 |
nephrotoxicity | 32 |
morphology | 32 |
panels | 32 |
penicillin | 32 |
phagocytes | 32 |
portion | 32 |
eosinophilia | 31 |
cytology | 31 |
enterocolitis | 31 |
eligibility | 31 |
drop | 31 |
den | 31 |
cytometric | 31 |
caspase | 31 |
compliance | 31 |
coinfection | 31 |
centrifugation | 31 |
cd | 31 |
allergen | 31 |
aid | 31 |
abs | 31 |
fluorescent | 31 |
error | 31 |
i. | 31 |
guidance | 31 |
profiling | 31 |
heparin | 31 |
volumes | 31 |
syphilis | 31 |
sampling | 31 |
references | 31 |
publications | 31 |
remissions | 31 |
past | 31 |
nuclei | 31 |
neuropathy | 31 |
neoplasm | 31 |
modifications | 31 |
melanoma | 31 |
interference | 31 |
erythrocyte | 30 |
grants | 30 |
gondii | 30 |
gap | 30 |
galcer | 30 |
foot | 30 |
file | 30 |
fertility | 30 |
excision | 30 |
assessments | 30 |
epidermidis | 30 |
entities | 30 |
disability | 30 |
consumption | 30 |
construct | 30 |
conflicts | 30 |
attack | 30 |
insurance | 30 |
hormone | 30 |
arrest | 30 |
jaundice | 30 |
reg | 30 |
meeting | 30 |
vd2 | 30 |
uv | 30 |
tubes | 30 |
thickening | 30 |
thawing | 30 |
supplementation | 30 |
stratification | 30 |
trecs | 30 |
pulse | 30 |
perspective | 30 |
pancreatitis | 30 |
oxygenation | 30 |
odds | 30 |
nursing | 30 |
negativity | 30 |
n=4 | 30 |
procurement | 30 |
honoraria | 29 |
exam | 29 |
expressions | 29 |
heat | 29 |
hemodialysis | 29 |
ligation | 29 |
hypoxemia | 29 |
immunizations | 29 |
integrity | 29 |
keratinocytes | 29 |
disruption | 29 |
downregulation | 29 |
belatacept | 29 |
determinants | 29 |
deletions | 29 |
databases | 29 |
cytopenia | 29 |
committee | 29 |
codon | 29 |
cluster | 29 |
ciprofloxacin | 29 |
chickenpox | 29 |
mosquito | 29 |
atelectasis | 29 |
additive | 29 |
limitation | 29 |
isoform | 29 |
norovirus | 29 |
sense | 29 |
opportunity | 29 |
weekly | 29 |
vitamin | 29 |
updates | 29 |
toxins | 29 |
today | 29 |
task | 29 |
t. | 29 |
stream | 29 |
spot | 29 |
spezifische | 29 |
shingles | 29 |
streptococci | 29 |
seed | 29 |
principle | 29 |
sdc | 29 |
participation | 29 |
perforation | 29 |
poliovirus | 29 |
prednisolone | 29 |
p=0.02 | 29 |
promise | 29 |
purposes | 29 |
responder | 29 |
schedules | 29 |
deviations | 28 |
coat | 28 |
crisis | 28 |
decay | 28 |
definitions | 28 |
demonstration | 28 |
dilution | 28 |
digestion | 28 |
cardiac | 28 |
disparity | 28 |
editing | 28 |
electroporation | 28 |
escalation | 28 |
cd62l | 28 |
abstracts | 28 |
ca | 28 |
c3 | 28 |
avoidance | 28 |
autograft | 28 |
architecture | 28 |
anxiety | 28 |
antagonist | 28 |
airways | 28 |
agammaglobulinemia | 28 |
adaptor | 28 |
activator | 28 |
acceptance | 28 |
exercise | 28 |
excretion | 28 |
ulceration | 28 |
fish | 28 |
referral | 28 |
yields | 28 |
verursacht | 28 |
tecs | 28 |
gf | 28 |
stenosis | 28 |
splenocytes | 28 |
spite | 28 |
sorting | 28 |
scenario | 28 |
ruxolitinib | 28 |
resonance | 28 |
rejections | 28 |
tbf | 28 |
purification | 28 |
pretransplant | 28 |
pbscs | 28 |
offspring | 28 |
nets | 28 |
morbidities | 28 |
mixture | 28 |
methodology | 28 |
lobe | 28 |
lectin | 28 |
inoculation | 28 |
hypersensitivity | 28 |
hazards | 28 |
enrollment | 27 |
estimate | 27 |
evaluations | 27 |
gilt | 27 |
explanation | 27 |
followup | 27 |
fractures | 27 |
electrophoresis | 27 |
engineering | 27 |
coagulopathy | 27 |
dyspnea | 27 |
dln | 27 |
description | 27 |
cxcr4 | 27 |
coronaviruses | 27 |
clusters | 27 |
cgy | 27 |
burst | 27 |
auc | 27 |
head | 27 |
hd | 27 |
fibroblast | 27 |
histocompatibility | 27 |
questionnaires | 27 |
− | 27 |
virology | 27 |
transition | 27 |
transcriptase | 27 |
thousands | 27 |
tetramers | 27 |
tap | 27 |
sizes | 27 |
similarity | 27 |
inactivation | 27 |
present | 27 |
particle | 27 |
myelofibrosis | 27 |
multiorgan | 27 |
microenvironment | 27 |
microangiopathy | 27 |
layers | 27 |
internalization | 27 |
paucity | 27 |
dasatinib | 26 |
considerations | 26 |
contraindication | 26 |
correlations | 26 |
existence | 26 |
elevations | 26 |
eosinophils | 26 |
erfolgen | 26 |
compatibility | 26 |
congestion | 26 |
basophils | 26 |
cascade | 26 |
blinatumomab | 26 |
behavior | 26 |
axis | 26 |
alt | 26 |
allosct | 26 |
allergens | 26 |
abdomen | 26 |
extracts | 26 |
extension | 26 |
empfohlen | 26 |
germ | 26 |
parenchyma | 26 |
µg | 26 |
il-1b | 26 |
wildtype | 26 |
sugarcane | 26 |
stroke | 26 |
septicemia | 26 |
quantities | 26 |
polysaccharide | 26 |
pathologies | 26 |
stimulus | 26 |
opinion | 26 |
neuraminidase | 26 |
nerve | 26 |
neg | 26 |
independence | 26 |
malnutrition | 26 |
living | 26 |
nurses | 26 |
intake | 26 |
experiment | 25 |
dlis | 25 |
droplet | 25 |
eine | 25 |
element | 25 |
ethnicity | 25 |
glands | 25 |
extract | 25 |
foci | 25 |
ice | 25 |
infectivity | 25 |
instructions | 25 |
descent | 25 |
display | 25 |
blotting | 25 |
deficits | 25 |
colostrum | 25 |
colonoscopy | 25 |
circumstances | 25 |
chromatography | 25 |
chromatin | 25 |
cardiomyopathy | 25 |
candidemia | 25 |
bronchitis | 25 |
bispecific | 25 |
bis | 25 |
antitoxin | 25 |
advent | 25 |
+4 | 25 |
lead | 25 |
intranuclear | 25 |
rearrangement | 25 |
melphalan | 25 |
season | 25 |
methylprednisolone | 25 |
≤ | 25 |
warts | 25 |
virions | 25 |
ulcer | 25 |
tomato | 25 |
thymocyte | 25 |
tage | 25 |
synapse | 25 |
swabs | 25 |
surfaces | 25 |
sp | 25 |
signatures | 25 |
sessions | 25 |
theory | 25 |
rheumatoid | 25 |
pneumocytes | 25 |
neoplasia | 25 |
relationships | 25 |
nitric | 25 |
nucleotides | 25 |
placement | 25 |
plaques | 25 |
ph | 25 |
polarization | 25 |
pox | 25 |
predominance | 25 |
pretransplantation | 25 |
propensity | 25 |
developments | 24 |
glycoproteins | 24 |
disappearance | 24 |
donations | 24 |
exhaustion | 24 |
flora | 24 |
gland | 24 |
glass | 24 |
kind | 24 |
imatinib | 24 |
immunophenotype | 24 |
immunophenotyping | 24 |
indicators | 24 |
ip | 24 |
language | 24 |
degranulation | 24 |
dehydrogenase | 24 |
aa | 24 |
decontamination | 24 |
cellularity | 24 |
lengths | 24 |
/l | 24 |
antigenemia | 24 |
aspirates | 24 |
assembly | 24 |
blocks | 24 |
chip | 24 |
cytoskeleton | 24 |
classes | 24 |
consultation | 24 |
correction | 24 |
crp | 24 |
cultivation | 24 |
cysts | 24 |
leaves | 24 |
cellulitis | 24 |
leukoencephalopathy | 24 |
school | 24 |
spores | 24 |
stock | 24 |
stomach | 24 |
swelling | 24 |
testosterone | 24 |
text | 24 |
thresholds | 24 |
∈ | 24 |
usefulness | 24 |
utis | 24 |
wurde | 24 |
yeast | 24 |
über | 24 |
θ | 24 |
oncology | 24 |
sedation | 24 |
trigger | 24 |
s1p | 24 |
pta | 24 |
rna | 24 |
op | 24 |
parenchymal | 24 |
pbmc | 24 |
peri | 24 |
platforms | 24 |
pos | 24 |
periphery | 24 |
puncture | 24 |
reporting | 24 |
reservoir | 24 |
respondents | 24 |
retention | 24 |
pump | 24 |
return | 24 |
institute | 23 |
flag | 23 |
determinant | 23 |
documentation | 23 |
emphasis | 23 |
hantavirus | 23 |
gold | 23 |
ground | 23 |
ctla-4 | 23 |
dependence | 23 |
alcohol | 23 |
cryptosporidium | 23 |
cd8 | 23 |
carriage | 23 |
cacy | 23 |
brucellosis | 23 |
breakthrough | 23 |
bioavailability | 23 |
bead | 23 |
achievement | 23 |
interruption | 23 |
integration | 23 |
leukemias | 23 |
keine | 23 |
similarities | 23 |
± | 23 |
xenotransplantation | 23 |
vlps | 23 |
veno | 23 |
trafficking | 23 |
thyroiditis | 23 |
thyroid | 23 |
thiotepa | 23 |
snps | 23 |
verfügbar | 23 |
shrimp | 23 |
personnel | 23 |
saml | 23 |
lysate | 23 |
myelogenous | 23 |
o0.05 | 23 |
providers | 23 |
reagent | 23 |
reinfection | 23 |
row | 23 |
dnaemia | 22 |
experiences | 22 |
effectors | 22 |
embryo | 22 |
enlargement | 22 |
erythrocytes | 22 |
erythroid | 22 |
hpv | 22 |
fatality | 22 |
fate | 22 |
fields | 22 |
granzyme | 22 |
hygiene | 22 |
ig | 22 |
demand | 22 |
disturbances | 22 |
caregivers | 22 |
debate | 22 |
cars | 22 |
1st | 22 |
alloantigen | 22 |
atopy | 22 |
azathioprine | 22 |
b1 | 22 |
influx | 22 |
cart | 22 |
dapsone | 22 |
chemotaxis | 22 |
columns | 22 |
confi | 22 |
constraints | 22 |
counterparts | 22 |
crops | 22 |
income | 22 |
superinfection | 22 |
intensification | 22 |
tcrs | 22 |
serotherapy | 22 |
spectrometry | 22 |
stools | 22 |
substrate | 22 |
survivals | 22 |
targeting | 22 |
terminus | 22 |
scenarios | 22 |
tetramer | 22 |
thalidomide | 22 |
topic | 22 |
und | 22 |
isotype | 22 |
y. | 22 |
serologic | 22 |
vehicle | 22 |
rooms | 22 |
precision | 22 |
remainder | 22 |
lenalidomide | 22 |
mediator | 22 |
ml. | 22 |
mspcs | 22 |
paraffin | 22 |
passage | 22 |
lymphopenia | 22 |
predictions | 22 |
record | 22 |
reductions | 22 |
registration | 22 |
reagents | 22 |
regs | 22 |
following | 21 |
f1 | 21 |
favor | 21 |
fibrin | 21 |
fibrinogen | 21 |
fitting | 21 |
hybridoma | 21 |
foxn1 | 21 |
heads | 21 |
indicator | 21 |
intranasal | 21 |
leptospirosis | 21 |
esophagus | 21 |
library | 21 |
evs | 21 |
choices | 21 |
duct | 21 |
differential | 21 |
cytarabine | 21 |
contents | 21 |
computation | 21 |
coagulase | 21 |
cloning | 21 |
chitosan | 21 |
character | 21 |
carbohydrate | 21 |
brosis | 21 |
autoantibody | 21 |
asct | 21 |
0.002 | 21 |
metadata | 21 |
locations | 21 |
rvis | 21 |
monocytogenes | 21 |
relative | 21 |
mosaic | 21 |
variance | 21 |
users | 21 |
tubules | 21 |
transaminases | 21 |
tnf | 21 |
titre | 21 |
thickness | 21 |
spleens | 21 |
society | 21 |
service | 21 |